<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02226887</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)288/2013</org_study_id>
    <nct_id>NCT02226887</nct_id>
  </id_info>
  <brief_title>Prophylaxis of Ileostomy Closure Site Hernia by Placing Mesh</brief_title>
  <acronym>ILEOCLOSE</acronym>
  <official_title>&quot;Prospective Randomized Clinical Trial of Ileostomy Closure Site Hernia and it´s Prophylaxis by Placing an Absorbable Mesh &quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Design Prospective , randomized, parallel phase IV.&#xD;
&#xD;
      Objectives Main objective&#xD;
&#xD;
        -  Evaluate the effectiveness of the placement of a resorbable mesh in the prevention of&#xD;
           incisional hernia of the abdominal wall at the site of a loop ileostomy when it is&#xD;
           &quot;closed &quot; to rebuild the intestinal transit. The effectiveness evaluation is done by&#xD;
           tracking with scheduled patient visits for 12 months, assessing the physical examination&#xD;
           the presence or absence of an incisional hernia and an abdominal tomography at the end&#xD;
           of the 12 months .&#xD;
&#xD;
      Secondary objectives Comparison of complications(morbidity and mortality) to assess safety&#xD;
      and tolerability of the placement of the mesh described .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental: Reinforcement with Absorbable Mesh Closure of the ileostomy closure incision is&#xD;
      reinforced with insertion of a rectangular segment (1 cm wide and the length corresponding to&#xD;
      the incision) of a prosthetic commercially available GORE® BIO-A® Tissue Reinforcement&#xD;
      prosthesis (W. L. Gore &amp; Associates, Flagstaff, Arizona, USA) mesh. The BIO-A® prosthesis is&#xD;
      inserted using a &quot;sandwich&quot; method between the edges of the incision and maintained in situ&#xD;
      with a continuous polydioxanone (PDS) suture following a suture length to wound length&#xD;
      (SL:WL) ratio of 4:1.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Eventration</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by clinical checks at 1 - 6 - 12 months and Abdominal tomography 1 year after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occlusive problems</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Intestinal occlusion, Anastomotic stenosis, Prolonged ileus(&gt;5days),....&#xD;
This is a Clinical measure supported by image if necessary&#xD;
All the morbidity problems are reported independently.&#xD;
1 patient can suffer a prolonged ileus and Anastomotic stenosis and both will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iatrogenic problems</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Damage to structures such as ureters, bowel loops artery / iliac vein ....&#xD;
This is a Surgical and Clinical measure supported by image if necessary.&#xD;
All the morbidity problems are reported independently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impaired healing</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Anastomotic leak rate , intestinal fistula , vesical fistula, peritonitis...&#xD;
This is a Clinical measure always supported by image tests.&#xD;
All the morbidity problems are reported independently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding problems</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Hemoperitoneum, abdominal hematoma,anastomotic bleeding ....&#xD;
This is a Clinical measure supported by image if necessary.&#xD;
All the morbidity problems are reported independently.&#xD;
The amount of blood loss won't be specified</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>acute myocardial infarction, angor pectoris , atrial fibrillation, acute pulmonary edema&#xD;
This is a Clinical measure supported by more specific tests if necessary.&#xD;
All the morbidity problems are reported independently.&#xD;
Cardiologist report will be required for including this items</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nephro-urinary complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Acute urinary retention, Acute renal failure, cystitis, pyelonephritis ...&#xD;
This is a Clinical measure supported by more specific tests if necessary.&#xD;
All the morbidity problems are reported independently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Pneumonia, Atelectasis, Pulmonary embolism, Respiratory distress syndrome ...&#xD;
This is a Clinical measure always supported by image .&#xD;
All the morbidity problems are reported independently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Deep venous thrombosis, phlebitis, thrombophlebitis, ...&#xD;
This is a Clinical measure supported by more specific test if necessary .&#xD;
All the morbidity problems are reported independently</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Liver failure, gastrointestinal bleeding, severe malnutrition, ...&#xD;
This is a Clinical measure supported by blood test and further test if necessary&#xD;
All the morbidity problems are reported independently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Disorientation, cerebral vascular accident, ...&#xD;
This is a Clinical measure.&#xD;
All the morbidity problems are reported independently.&#xD;
Neurologist report will be required beyond disorientation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local infection</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Superficial, deep, body-cavity&#xD;
This is a Clinical measure supported by image if necessary&#xD;
All the morbidity problems are reported independently</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Hematoma, seroma, evisceration&#xD;
This is a Clinical measure&#xD;
All the morbidity problems are reported independently</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Days</time_frame>
    <description>Hospital stay since surgery is done</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Loop Ileostomy Closure</condition>
  <arm_group>
    <arm_group_label>MESH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>NO MESH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MESH</intervention_name>
    <description>Pre-operative :&#xD;
It was made by barium enema protocol and transanal endoscopy to rule out anastomotic leaks or strictures contraindicating stoma closure .&#xD;
Surgical technique:&#xD;
Peristomal incision with electrocautery&#xD;
Release the handle of ileum&#xD;
Anastomosis made the with the segment everted sutured by simple manual end to end 3/0 or mechanical side to side (surgeon's election).&#xD;
Return the ileum into the abdominal cavity and the fascial defect is repaired with continuous polydioxanone 1/0 suture respecting 4:1 measurement rule.&#xD;
We add the mesh between the edges of the defect during fascia closure.&#xD;
The skin is sutured &quot;purse string&quot; style.&#xD;
Post-Op&#xD;
Hospital discharge after verification of normal digestive transit.</description>
    <arm_group_label>MESH</arm_group_label>
    <other_name>Mesh : GORE® BIO-A®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NO MESH</intervention_name>
    <description>Pre-operative :&#xD;
It was made by barium enema protocol and transanal endoscopy to rule out anastomotic leaks or strictures contraindicating stoma closure .&#xD;
Surgical technique:&#xD;
Peristomal incision with electrocautery&#xD;
Release the handle of ileum&#xD;
Anastomosis made the with the segment everted sutured by simple manual end to end 3/0 or mechanical side to side (surgeon's election).&#xD;
Return the ileum into the abdominal cavity and the fascial defect is repaired with continuous polydioxanone 1/0 suture respecting 4:1 measurement rule.&#xD;
The skin is sutured &quot;purse string&quot; style.&#xD;
Post-Op&#xD;
- Hospital discharge after verification of normal digestive transit</description>
    <arm_group_label>NO MESH</arm_group_label>
    <other_name>Protocol Ileostomy closure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Post-operative Imaging</intervention_name>
    <description>Abdominal Tomography 1 year after ileostomy closure</description>
    <arm_group_label>MESH</arm_group_label>
    <arm_group_label>NO MESH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Pre-operative Imaging</intervention_name>
    <description>Contrast study is used to ensure the integrity of the distal anastomosis</description>
    <arm_group_label>MESH</arm_group_label>
    <arm_group_label>NO MESH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood Test and C-reactive protein at 4th day</intervention_name>
    <description>All patients undergo a Blood Test study of C-reactive protein on day 4 by protocol within the unit before discharge.</description>
    <arm_group_label>MESH</arm_group_label>
    <arm_group_label>NO MESH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing a loop ileostomy closure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18&#xD;
&#xD;
          -  Pregnancy and Lactation&#xD;
&#xD;
          -  Patients allergic to polyglycolic / trimethylene carbonate&#xD;
&#xD;
          -  Carrier of prosthetic mesh in the ostomy&#xD;
&#xD;
          -  Patients presenting midline hernia.&#xD;
&#xD;
          -  Patients affected by inflammatory bowel disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borja Villanueva Figueredo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesc Vallribera Valls, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'Hebron Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Lopez-Cano, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'Hebron Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General Universitario Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Borja Villanueva, MD</last_name>
      <phone>+34 629801238</phone>
      <email>b.villanueva@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Borja Villanueva Figueredo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>August 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2014</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Loop ileostomy</keyword>
  <keyword>Eventration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

